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Abstract 
Lymphoepithelial carcinoma of the salivary
glands is a rare neoplasm that is character-
ized by a non-neoplastic lymphocytic infiltra-
tion associated with an epithelial prolifera-
tion.  It  involves  mainly  the  parotid  gland.
Racial and geographical factors contribute to
the pathogenesis of this tumor. We report a
case  of  a  70-year  old  woman  from  a  non-
endemic  area  who  presented  with  several
months  history  of  swelling  in  the  parotid
region. Magnetic resonance imaging showed
a parotid mass suggestive of a pleomorphic
adenoma. The diagnosis of lymphoepithelial
carcinoma of the parotid gland was performed
on  the  surgical  specimen.  A  primitive
nasopharyngeal carcinoma was ruled out by
random biopsies of the nasopharynx mucosa.
The Epstein-Barr virus (EBV) was absent in
neoplastic cells. We insist that, even in non-
endemic areas and when clinical and radio-
logical characteristics are not suggestive of
malignancy,  intra-operative  frozen  section
analysis should be used in order to ensure the
appropriate treatment. 
Introduction 
Lymphoepithelial  carcinoma  (LEC)  is  a
specific subtype of undifferentiated carcino-
ma with characteristic dense lymphoid stro-
ma.  The  most  frequent  location  is  the
nasopharynx.  Identical  tumors  have  been
rarely described in the major salivary glands
where they account for approximately 0.4% of
all malignant salivary gland tumors.
1 A limited
number  of  cases  were  reported  from  non-
endemic areas. We report a new case from a
non-endemic region with an atypical clinical
presentation  and  an  aspecific  radiological
pattern and we discuss the clinical and patho-
logical  pattern  and  management  of  this
uncommon tumor. 
Case Report
A 70-year old women presented with a left
sided,  slowly  enlarging,  painless,  non-tender
mass in the parotid region of several months’
duration. Her medical and surgical history was
otherwise  uneventful.  On  physical  examina-
tion, in the left parotid gland she had a volumi-
nous mass of 7 cm with a regular border that
was mobile on the superficial and deep planes,
and  did  not  hurt  upon  palpation.  Her  facial
nerve function was intact, and no enlarged cer-
vical lymph nodes were palpated. The remain-
ing systemic examination did not reveal any
coexistent lesions. Magnetic resonance imag-
ing detected a 7x6x6 cm mass in the superficial
lobe of the left parotid that was interpreted as
most likely representing a pleomorphic adeno-
ma (Figure 1). The patient underwent a left
parotidectomy,  and  the  facial  nerve  was  left
anatomically intact. Her recovery was unevent-
ful. Macroscopically, there were multiple surgi-
cal specimens that were brownish and firm in
consistency. Histological findings demonstrat-
ed a tumor located in the parotid gland that was
made of irregular sheets, islands and strands of
poorly differentiated carcinoma richly infiltrat-
ed by lymphocytes and plasma cells, accompa-
nied by large lymphoid follicles (Figure 2). The
epithelial  component  consisted  of  large  cells
with indistinct cell borders resulting in synci-
tial  appearance,  eosinophilic  cytoplasm  and
oval  vesicular  nuclei  (Figure  3).  The  nuclei
contained open chromatin material with promi-
nent  nucleoli.  Frequent  mitotic  figures  were
also found. Areas of squamous differentiation
were  noted.  The  surrounding  parotid  tissue
showed  a  chronic  lithiasic  sialadenitis.
Immunohistochemically,  most  of  the  tumor
cells were positive for cytokeratin (Figure 4).
The surrounding cellular infiltrate were a mix-
ture of CD20 and CD3 positive B and T lympho-
cytes. Immunohistochemical expression of EBV
latent membrane protein 1 (LMP1) and in situ
hybridization to EBV encoded RNA were nega-
tive. These findings were consistent with the
diagnosis  of  primary  LEC  of  the  left  parotid
gland after excluding metastatic nasopharyn-
geal undifferentiated carcinoma to the parotid
gland by random biopsies from the nasopharyn-
geal mucosa. The patient underwent an ipsilat-
eral radical neck dissection and there were no
lymph node metastases. She remains alive and
disease free five months after treatment.
Discussion
According to the classification by Ellis and
Auclair,
2 undifferentiated  carcinomas  of  the
salivary glands can be subtyped further into
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Figure  1.  Magnetic
resonance  imaging
showing  a  well  cir-
cumscribed mass of
the  left  parotid
gland.[Rare Tumors 2009; 1:e16] [page 45]
small  cell  undifferentiated  carcinoma,  large
cell  undifferentiated  carcinoma,  and  LEC.
LEC  accounts  for  approximately  0.4%  of
malignant  salivary  gland  tumors  and  has  a
characteristic extensive and dense lymphoid
stroma.
1 This tumor affects the parotid gland
in  approximately  80%  of  the  cases.
3 Most
cases occur in the fifth decade of life and a
predilection for female patients is reported.
4
There  is  a  racial  prevalence  in  Inuits
(Eskimo) in the Arctic region, south-eastern
Chinese  and  Japanese.  Most  parotid  LEC
cases arise de novo, but they may rarely devel-
op within lymphoepithelial sialadenitis.
5 The
exact origin and pathogenesis of parotid LEC
remains unknown. Among the possible etiolo-
gies  are  a  malignant  transformation  of  the
glandular and ductal inclusions in the intra-
parotid lymph nodes
6 and a malignant trans-
formation of the epi-myoepithelial island.
7 In
1991, the presence of EBV was detected by
Hamilton-Dutoit et al.
8 in the malignant cells
of salivary LECs in the Eskimo population of
Greenland. Only a few cases of EBV-negative
LEC  have  been  reported,  and  almost  exclu-
sively in non-Inuit patients
6 suggesting that
the virus plays a role in the etiology of LEC.
The  association  of  EBV  with  salivary  gland
LEC may also exist in non-endemic areas.
4 It
seems there is a complex interaction between
genetic  factors,  environmental  factors,  and
EBV  infection  in  the  oncogenic  process  of
LEC of the salivary glands.
9 Parotid LEC usu-
ally  presents  as  an  enlarging  parotid  lump,
occasionally  painful  and  with  facial  nerve
involvement in approximately 20% of cases.
4
Clinical  features  suggestive  of  malignancy
are rapid-growing course, pain or tenderness,
progressive  facial  nerve  palsy  and  obvious
cervical lymphadenopathy.
10 Our case is par-
ticular for the atypical presentation suggest-
ing  a  benign  lesion;  in  fact,  our  patient
showed  no  signs  suggestive  of  malignancy.
On presentation, up to 40% of patients have
metastases to the cervical lymph nodes, 20%
develop  local  recurrence  or  lymph  node
metastases, and 20% have distant metastases
within three years following therapy. Distant
metastases  usually  involve  the  lung,  liver,
bone,  and  brain.
1 Macroscopically,  these
tumors are firm, 1-10 cm masses, multinodu-
lar, circumscribed, or clearly infiltrative into
adjacent salivary gland, fat, muscle, or skin,
with a cut surface that varies from a grey-tan
to yellow-gray.
11 Histologically, it is character-
ized by a syncitial growth pattern and a dense
stroma  made  of  non-neoplastic  lymphoplas-
macytic  cells;  the  lymphoid  cells  include  a
mixture of B and C cells and are sometimes
associated with germinal centers. The epithe-
lial  component  is  composed  of  irregular
shaped islands, cords, trabeculae of pleomor-
phic,  large,  malignant  cells  with  abundant
lightly  eosinophilic  cytoplasm  and  vesicular
nuclei.
3,12 Mitotic rate is variable. Histiocytes
are abundant in the tumor islands in some
cases,  imparting  a  'starry  sky'  appearance.
3
Other inconsistent findings are non-caseat-
ing granulomas with or without multinucleat-
ed giant cells and amyloid deposition.
13 A def-
inite squamous differentiation with intercel-
lular bridges has been identified in several
cases.
3 LEC is indistinguishable from undif-
ferentiated nasopharyngeal carcinoma which
is  much  more  common  or  other  LECs  that
develop  in  various  parts  of  the  body.
4,10
Therefore,  to  confirm  the  diagnosis  of  pri-
mary  LEC  in  the  major  salivary  glands,
metastatic nasopharyngeal carcinoma to the
salivary glands should be eliminated through
examination of the upper aerodigestive tract
with endoscopy and even random biopsy of
the nasopharynx.
3,4,10,13 In reality, the parotid
gland is the predominant site of occurrence of
LEC  and  an  exceptional  site  of  metastasis
from nasopharyngeal carcinoma, which more
typically metastasizes to the cervical or sub-
mandibular lymph nodes.
1 Histologically, the
LEC  must  be  distinguished  from  benign
lesions such as lymphoepithelial sialadenitis
and from other epithelial malignancies, such
as primary or metastatic poorly differentiated
squamous  cell  carcinoma,  adenocarcinoma,
and amelanotic melanoma; another differen-
Case Report
Figure  2.  Lympho-
epithelial lesion of the
parotid  gland  (hema-
toxylin-eosin,  original
magnification  ×40).
Islands  of  neoplastic
epithelial cells (arrows)




Figure 3. The epithelial
component  of  the
lesion have a syncitial
appearance and shows
an  obvious  pleomor-
phism  (hematoxylin-
eosin,  original  magni-
fication ×400). 
Figure  4.  Immunohi-
stochemical  expression
of cytokeratin (×400).[page 46] [Rare Tumors 2009; 1:e16]
tial diagnosis is with large cell or anaplastic
types of lymphoma.
2 The optimal management
of LEC of the major salivary glands is com-
plete excision with clear surgical margins fol-
lowed by adjuvant radiotherapy to the tumor
bed and neck. 
Neck  dissection  is  reserved  for  patients
who  have  clinically  positive  cervical  lymph
nodes.
10,14 Our patient underwent only surgical
treatment  because  radiotherapy  was  not
available at that time. Lymphoepithelial carci-
noma seems to have a better prognosis than
the other undifferentiated carcinomas of the
salivary glands, in part because of the lym-
phoid stroma that has a role in limiting the
aggressiveness of this carcinoma. Advanced
disease, the presence of metastases on diag-
nosis, and histological features such as high
mitotic rate, anaplasia, and necrosis are pre-
dictors of a worse prognosis.
1,9 The 5-year sur-
vival rate has been reported to range from 50-
87%.
10
In conclusion, it is worth underlining the
diagnostic difficulty in this case caused by the
absence  of  clinical  symptoms  suggestive  of
malignancy and the non-specific nature of the
radiological signs. In order to ensure a correct
therapeutic approach, intra-operative frozen
section analysis of a parotid mass should be
used to exclude a malignant tumor even when
dealing with a clinical and radiological pres-
entation suggestive of pleomorphic adenoma.
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